<unk>  which is the abbreviation for<unk> " was a prospective clinical trial conducted in 85 sites in 17 countries across Europe and the United States.  The purpose of this study was to compare<unk>  stenting and cardiac<unk>  revascularization strategies for patients with previously untreated 3-vessel disease or left main coronary artery disease and to identify the populations for whom one strategy would be better than the other.  Previous clinical trials comparing bare metal stents with coronary artery bypass graft (CABG)<unk>  had shown similar survival rates but higher revascularization rates in patients treated with bare metal stents.  Randomized clinical trials have also shown drug eluting stents (DES) as compared with Bare Metal Stents (BMS), to show better results in terms of repeat revascularization.  The<unk>  trial was conducted to assess the efficacy of<unk>  which is a Paclitaxel drug eluting stent as compared to CABG for effective means of revascularization in patients with three vessel disease or left main disease.
Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery
PCI in The Patient With Resistance to Aspirin
Appropriate use criteria for revascularization
Cardiac resynchronization therapy pathophysiology
Coronary artery bypass surgery heart team approach to revascularization decisions
Cardiac resynchronization therapy complications
Coronary artery bypass surgery after failed PCI
Predictors of coronary stent thrombosis